4 février 2016

<link file:9335 download le téléchargement>Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement : a phase III, randomised, controlled trial (PALACE 3) Edwards et al. Ann Rheum Dis. 2016 Jan 20